atenolol has been researched along with hydrochlorothiazide in 232 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (19.83) | 18.7374 |
| 1990's | 59 (25.43) | 18.2507 |
| 2000's | 58 (25.00) | 29.6817 |
| 2010's | 63 (27.16) | 24.3611 |
| 2020's | 6 (2.59) | 2.80 |
| Authors | Studies |
|---|---|
| Ax, F; Bonham, NM; Hallberg, A; Karlén, A; Lennernäs, H; Winiwarter, S | 1 |
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Faller, B; Wohnsland, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Gudbrandsson, T; Hansson, L | 1 |
| Giese, J; Ibsen, H; Leth, A; McNair, A | 1 |
| Andrews, CD; Bulpitt, CJ; Callaghan, TS; Fletcher, AE; Palmer, AJ; Rudge, PJ | 1 |
| Dahlöf, B; Ekbom, T; Hansson, L; Lindholm, LH; Scherstén, B; Wester, PO | 1 |
| Erikssen, J; Froeland, G; Otterstad, JE; Saltvedt, E; Soeyland, AK | 1 |
| Huttunen, M; Ikäheimo, M; Kontro, J; Lampainen, E; Lilja, M; Mäkynen, P; Savolainen, A | 1 |
| Thurston, H | 1 |
| McGrath, BP; McNeil, JJ; Silagy, CA | 1 |
| Kim, M; Riley, SA; Rowland, M; Sutcliffe, F; Turnberg, LA | 1 |
| Ekeli, T; Froeland, G; Knutsen, KM; Otterstad, JE; Wasenius Soeyland, AK | 1 |
| Ekeli, T; Froeland, G; Michelsen, S; Otterstad, JE | 1 |
| Froeland, G; Illingworth, JM; Otterstad, JE; Soeyland, AK | 1 |
| Dohmoto, H; Fujiyoshi, T; Hashiguchi, Y; Hayashi, Y; Hosono, M; Iida, H; Ikeda, K; Yoshimoto, R | 1 |
| Kapas, M; Kim, M; Riley, SA; Rowland, M; Sutcliffe, F; Turnberg, LA | 2 |
| Goldstein, DS; Turkkan, JS | 1 |
| Goldstein, RJ | 1 |
| Desche, P; Thurston, H | 1 |
| Chappel, C; Chrysant, SG; Farnham, DJ; Levin, B; Lueg, M; McCluskey, D; Steiner, C | 1 |
| Hörrmann, M; Machwirth, M; van der Does, R; Widmann, L | 1 |
| Hörrmann, M; Machwirth, M; Stienen, U; Uberbacher, HJ; van der Does, R; Widmann, L | 1 |
| Cheadle, B; Duckett, GK | 1 |
| Blumenthal, JA; Ekelund, LG; Emery, CF | 1 |
| Chalmers, J; Taylor, S; Wing, L | 1 |
| Brown, P; Haider, B; Silas, E; Zaeh, D | 1 |
| Desche, P; Zanchetti, A | 1 |
| Behr, U; Franz, IW; Ketelhut, R; Tönnesmann, U | 1 |
| Duman, EL; Komsuoğlu, B; Komsuoğlu, SS; Ozgür, O | 1 |
| Amstein, R; Beretta-Piccoli, C; Bertel, O; Brunner, HR; Bühler, FR; Follath, F; Reutter, F; Vallotton, MB | 1 |
| Hagelund, CH; Helgeland, A; Strømmen, R; Tretli, S | 2 |
| Bune, AJ; Chalmers, JP; Elliott, JM; Morris, MJ; Russell, AE; West, MJ; Wing, LM | 1 |
| Beckman, S | 1 |
| Ghosh, AK | 1 |
| Dahlöf, B; Hansson, L; Lindholm, L; Råstam, L; Scherstén, B; Wester, PO | 1 |
| Itskovitz, HD; Khoury, S; Krug, K; Mollura, JL | 1 |
| Cox, DA; Leader, JP; Milson, JA; Singleton, W | 1 |
| Gray, D; Moon, R; Musgrove, J; Pascoe, J | 1 |
| Burgess, J; Cooper, WD; Davidson, C; Fairhurst, G; Petrie, JC; Richardson, PJ; Robb, OJ; Trafford, J; Vandenburg, MJ; Webster, J | 1 |
| Parag, KB; Seedat, YK | 1 |
| Alicandri, C; Boni, E; Fariello, R; Muiesan, G; Zaninelli, A | 1 |
| Leary, WP; Maharaj, B; van der Byl, KV | 1 |
| Philip, IG; Qureshi, SM; Richards, HH; Rowley-Jones, D; Sharma, SK; Wright, FG; Young, PH | 1 |
| Moroni, G; Poggio, F; Salvadeo, A; Segagni, S; Villa, G | 1 |
| Adam, G; Jackson, G; Jackson, PG; MacFarlane, E; Rowland, M | 1 |
| Holzgreve, H; Middeke, M; Schwandt, P; Weisweiler, P | 1 |
| Jutrin, I; Lang, R; Lischner, M; Ravid, M | 1 |
| Adam, HK; Castleden, CM; Fitzsimons, TJ; Ryan, J; Sabanathan, K | 1 |
| Bettazzi, L; Cirò, A; Civelli, M; Folli, G; Mancarella, S; Oltrona, L; Secchi, MB; Wu, SC | 1 |
| Andrén, L; Hansson, L; Karlberg, BE; Nilsson, OR; Ohman, P; Svensson, A | 1 |
| Kawecka-Jaszcz, K; Kocemba, J; Wojciechowska, M | 1 |
| Hengeveld, WL; Schouten, JA; Westerman, RF | 1 |
| Gamio Capestany, F; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A | 1 |
| Holzgreve, H; Middeke, M | 1 |
| Shen, JQ; Wang, LD | 1 |
| Banderali, G; Carnovali, M; Crespi, E; Missaglia, A; Ponti, GB | 1 |
| Schoeman, HS; Sommers, DK; van Wyk, M | 1 |
| Andrén, L; Hansson, L; Svensson, A | 1 |
| Donker, AJ; May, JF; Schuurman, FH; ten Berge, BS; van der Veur, E; Wesseling, H | 1 |
| Freslon, JL; Giudicelli, JF; Richer, C | 1 |
| Friedrich, G; Neus, H; Rüdel, H; Schmieder, R; von Eiff, AW | 1 |
| Friedrich, G; Neus, H; Rüddel, H; Schulte, W; von Eiff, AW | 1 |
| Bentivoglio, M; Corea, L; Verdecchia, P | 1 |
| Galli, F; Piazza, V; Salvadeo, A; Segagni, S; Villa, G | 1 |
| Andrén, L; Asplund, J; Hansson, L; Karlberg, B; Ohman, P; Svensson, A | 1 |
| Danielson, M; Lundbäck, M | 1 |
| Friedrich, G; Neus, H; Rüddel, H; Schmieder, R; von Eiff, AW | 1 |
| Albanesi Filho, FM; Brandão, AP; Oigman, W | 1 |
| Amabile, G; Bory, M; De Luca, N; Denis, B; Imbs, JL; Lahiri, A; Marchegiano, R; Raftery, EB; Senior, R; Zannad, F | 1 |
| Fogari, R; Malamani, GD; Marasi, G; Vanasia, A; Villa, G; Zoppi, A | 1 |
| Dunlay, MC; Goldberg, AI; Sweet, CS | 1 |
| Ames, RP; Applegate, WB; Burris, JF; Davidov, ME; Mroczek, WJ; Ram, CV | 1 |
| Alli, C; Avanzini, F; Bettelli, G; Colombo, F; Corso, R; Mariotti, G; Radice, M; Tognoni, G; Torri, V | 1 |
| Brennan, PJ; Lever, AF | 1 |
| Bartels, DW; Benz, JR; Due, DL; Hall, WD; Kostis, JB; Peng, A; Perry, HM; Sirgo, M; Townsend, RR | 1 |
| Carruthers, G; Dessain, P; Fodor, G; Newman, C; Palmer, W; Sim, D | 1 |
| Lacourcière, Y; Lefebvre, J; Poirier, L; Provencher, P | 1 |
| Cushman, WC; Freis, ED; Fye, C; Gottdiener, J; Hamburger, RJ; Kochar, MS; Lakshman, R; Massie, BM; Materson, BJ; Reda, DJ | 1 |
| Erikssen, J; Froeland, G; Otterstad, JE | 1 |
| Chrysant, S; Dunlay, MC; Fitzpatrick, V; Francischetti, EA; Goldberg, AI; Sweet, CS | 1 |
| Aron, DC; Aucott, JN; Dombrowski, R; Fuehrer, SM; Laich, J; Pelecanos, E | 1 |
| Bird, A; Blizard, R; Lewis, G; Mann, A; Prince, M | 1 |
| Dees, A; Derkx, FH; Krijnen, P; Man in't Veld, AJ; Pieterman, H; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ | 1 |
| Ayrton, J; Collett, A; He, YL; Rowland, M; Sims, E; Walker, D; Warhurst, G | 1 |
| Anson, O; Neumann, L; Paran, E | 1 |
| Inada, Y; Kanagawa, R; Nishikawa, K; Ojima, M; Sanada, T; Wada, T | 1 |
| de Leeuw, PW; Notter, T; Zilles, P | 1 |
| Anderson, RJ; Gottdiener, JS; Massie, BM; Materson, BJ; Reda, DJ; Williams, DW | 1 |
| Anlauf, M; Distler, A; Holzgreve, H; Michaelis, J; Philipp, T; Wellek, S | 1 |
| Dollerup, J; Hotnes, T; Mogensen, CE; Os, I | 1 |
| Anlauf, M; Distler, A; Gärtner, H; Holzgreve, H; Kribben, A; Michaelis, J; Philipp, T; Philipp, U; Röcker, L; Schäfers, R; Wellek, S | 1 |
| Moulopoulos, S; Stamatelopoulos, S; Zakopoulos, N | 1 |
| Hietanen, EK; Kantola, IM; Kataja, MJ; Pelttari, LH; Salo, TT | 1 |
| D'Orlando, L; Mercante, WP; Pertoldi, F | 1 |
| Parihar, C; Parimoo, P; Prasad, CV; Sunil, K | 1 |
| Black, HR; Elliott, WJ; Fakouhi, TD; Grambsch, P; Grandits, G; Grimm, RH; Hansson, L; Lacoucière, Y; Muller, J; Neaton, JD; Sleight, P; Weber, MA; White, WB; Williams, G; Wittes, J; Zanchetti, A | 1 |
| Thürmann, PA | 1 |
| Cushman, WC; Freis, ED; Lakshman, MR; Materson, BJ; Reda, DJ | 1 |
| Kantola, I; Pelttari, L; Salo, TM; Viikari, JS; Voipio-Pulkki, LM | 1 |
| Bischoff, I; Block, S; Fliser, D; Hanses, A; Joest, M; Mutschler, E; Ritz, E | 1 |
| Anderson, GM; Clark, JP; Gurwitz, JH; Lau, P; Rochon, PA; Shear, NH; Tu, JV | 1 |
| Gottdiener, JS | 1 |
| Grote, L; Hedner, J; Kraiczi, H; Peker, Y | 1 |
| Baiz, AQ; Bortman, G; Farsang, C; Garcia-Puig, J; Niegowska, J; Vrijens, F | 1 |
| Deichsel, G; Freytag, F; Meinicke, T; Schelling, A | 1 |
| Gariépy, J; Levenson, J; Moyse, D; Simon, A | 1 |
| Abrignani, MG; Barbagallo, M; Dominguez, LJ; Nardi, E; Novo, G; Novo, S; Strano, A | 1 |
| Deinum, J; Derkx, FH; Krijnen, P; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ | 1 |
| Aamar, S; Ben-Ishay, D; Bursztyn, M; Ghanem, J; Perk, G | 1 |
| Cushman, WC; Materson, BJ; Reda, DJ; Williams, DW | 1 |
| Park, JB; Pu, Q; Schiffrin, EL | 1 |
| Bovet, P; Burnier, M; Madeleine, G; Paccaud, F; Waeber, B | 1 |
| Devereux, RB; Palmieri, V | 1 |
| Aurup, P; Beevers, G; Dahlöf, B; de Faire, U; Devereux, RB; Edelman, J; Fyhrquist, F; Ibsen, H; Julius, S; Kjeldsen, SE; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Snapinn, S; Wedel, H | 1 |
| Anderson, A; Morgan, TO | 1 |
| Leenen, FH; Ruzicka, M | 1 |
| Dahlöf, B; Devereux, RB; Jern, S; Nieminen, MS; Oikarinen, L; Okin, PM; Papademetriou, V; Toivonen, L; Viitasalo, M; Wachtell, K | 1 |
| Alaupovic, P; Carlberg, B; Lindholm, LH; Persson, M; Samuelsson, O; Svensson, A | 1 |
| Baumgart, P | 1 |
| Ong, HT | 1 |
| Bakris, GL; Bristol, HA; Cangiano, JL; Cohen, JD; Cooper-DeHoff, RM; Erdine, S; Garcia-Barreto, D; Handberg, EM; Keltai, M; Kolb, HR; Kowey, P; Mancia, G; Marks, RG; Messerli, FH; Parmley, WW; Pepine, CJ | 1 |
| Castellano, PM; Ferraro, MC; Kaufman, TS | 1 |
| Chaves, J; Giner, V; Iradi, A; Lozano, JV; Redón, J; Sáez, GT; Tormos, C | 1 |
| Biriukova, LS; Ieromuzo, AA; Ivanov, AN; Medkova, IL; Mosiakina, LI | 1 |
| Grant, RW; Meigs, JB; Singer, DE | 1 |
| Boschmann, M; Engeli, S; Jordan, J; Kreuzberg, U; Luft, FC; Sharma, AM; Weidinger, G | 1 |
| Cooper-DeHoff, R; Elliott, WJ; Hewkin, AC; Kupfer, S; Pepine, CJ | 1 |
| Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
| Hanigan, MH; Krempl, GA; Shord, SS; Thompson, DM | 1 |
| Estacio, RO; Kamgar, M; McFann, KK; Nobakhthaghighi, N; Schrier, RW; Shamshirsaz, AA | 1 |
| Jiang, YY; Shen, FM; Su, DF; Xie, HH; Zhang, XF | 1 |
| Bakris, GL; Cohen, JD; Cooper-Dehoff, R; Erdine, S; Hewkin, AC; Kupfer, S; Messerli, FH; Pepine, CJ | 1 |
| Coelho, EB; da Silva, CA; Fazan, R; Nobre, F; Salgado, HC | 1 |
| Dahlöf, B; de Faire, U; Devereux, RB; Fyhrquist, F; Harris, KE; Hille, DA; Ibsen, H; Kjeldsen, SE; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H | 1 |
| Chiara Cavallini, M; Palmieri, V; Pini, R | 1 |
| Barba, J; Castellano, JM; Díez, J; González, A; López, B | 1 |
| Celebi, O; Kilic, T; Komsuoglu, B; Kozdag, G; Sahin, T; Ural, D; Ural, E | 1 |
| Benetos, A; Champion, A; Coca, A; Cooper-DeHoff, RM; Messerli, FH; Pepine, CJ; Zhou, Q | 1 |
| Kumar, V; Shah, RP; Singh, S | 1 |
| Mourad, JJ; Waeber, B | 1 |
| Bai, Y; Chen, J; Fan, X; Fu, C; Han, Y; Hui, R; Li, W; Shi, Y; Song, X; Sun, K; Wang, H; Wang, Y; Wu, H; Xin, Y; Yang, T; Zhou, X | 1 |
| Afzal, R; Pais, P; Pogue, J; Sigamani, A; Xavier, D; Yusuf, S | 1 |
| Bailey, K; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Curry, RW; Gong, Y; Gums, J; Johnson, JA; Schwartz, G; Turner, ST; Zineh, I | 1 |
| Afzal, R; Eikelboom, J; Gupta, R; Mohan, V; Pais, P; Sigamani, A; Teo, K; Thomas, N; Xavier, D; Yusuf, S | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Campbell, K; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Johnson, JA; Schmidt, S; Schwartz, GL; Turner, ST | 1 |
| Brody, R; Grossman, E; Peleg, E; Sharabi, Y | 1 |
| Dutta, TK; Madanmohan, T; Pavithran, P; Prakash, ES | 1 |
| Bakris, GL; Champion, A; Cooper-Dehoff, RM; Kupfer, S; Pepine, CJ; Zhou, Q | 1 |
| Champion, A; Cooper-DeHoff, RM; Handberg, EM; Legler, UF; Mancia, G; Pepine, CJ; Zhou, Q | 1 |
| Johnson, M; Manrique, C; Sowers, JR | 1 |
| Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Hall, K; Johnson, JA; Parekh, V; Turner, ST; Wen, S; Zineh, I | 1 |
| El-Haddad, B; Hammoud, D; Shahouri, S; Shaver, T | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Gong, Y; Gums, JG; Johnson, JA; Schwartz, GL; Turner, ST | 1 |
| Chakraborty, BS; Desai, J; Ghosh, C; Jha, V; Khamar, B; Patel, A; Shah, G; Shah, T | 1 |
| Dahlöf, B; Devereux, RB; Edelman, JM; Hille, DA; Kjeldsen, SE; Lindholm, LH; Okin, PM | 1 |
| Cameron, A; Ewen, M; Laing, RO; van Mourik, MS | 1 |
| Angeli, F; Mazzotta, G; Reboldi, G; Verdecchia, P | 1 |
| Cunha, FM; Fontes, V; Gusmão, JL; Ignez, EC; Mano, GP; Mion, D; Nishiura, JL; Ortega, KC; Pierin, AM; Segre, CA; Ventura, CG | 1 |
| Galceran, MT; Huerta-Fontela, M; Ventura, F | 1 |
| Chavan, UB; Deshpande, AD; Dighe, SB; Jagdale, SN; Kothapalli, LP; Nanda, RK; Thomas, AB | 1 |
| Hosseini, F; Mahmoudian, M; Nemati, F; Rahbar-Roshandel, N; Shafiei, M | 1 |
| Bailey, K; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Johnson, JA; Smith, SM; Turner, ST | 1 |
| Dahlöf, B; Devereux, RB; Kjeldsen, SE; Lindholm, LH; Okin, PM | 1 |
| Berwanger, O; Mion Júnior, D; Ortega, KC; Silva, GV; Tsuji, RL | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-Dehoff, RM; Duarte, JD; Gong, Y; Gums, JG; Johnson, JA; Langaee, TY; Tran, B; Turner, ST | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-Dehoff, RM; Gums, JG; Johnson, JA; Schwartz, GL; Turner, ST | 1 |
| Brown, MJ; Burton, TJ; Graggaber, J; Mir, FA; Stears, AJ; Watts, MM; Woods, SH | 1 |
| Elliott, WJ | 1 |
| Carey, KM; Comee, MR; Donovan, JL; Kanaan, AO | 1 |
| Afzal, R; Gao, P; Pais, P; Sigamani, A; Teo, KK; Xavier, D; Yusuf, S | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, EA; Chapman, AB; Cooper-DeHoff, RM; Del-Aguila, JL; Gong, Y; Gums, JG; Johnson, JA; Karnes, JH; Langaee, TY; McDonough, CW; Pepine, CJ; Turner, ST; Vo, TT | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gawronski, BE; Gong, Y; Gums, JG; Johnson, JA; Langaee, TY; Liggett, SB; Lobmeyer, MT; Pepine, CJ; Turner, ST; Vandell, AG | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Hou, W; Johnson, JA; Langaee, TY; McDonough, CW; Turner, ST; Wang, Z | 1 |
| Boor, P; Cohen, CD; Denecke, B; Eitner, F; Floege, J; Gan, L; Konieczny, A; Kunter, U; Neusser, MA; Ostendorf, T; Scholl, T; van Roeyen, CR; Villa, L | 1 |
| Cavazzini, A; Dondi, F; Marchetti, N; Martucci, A; Pasti, L; Sarti, E | 1 |
| Dahlöf, B; Devereux, RB; Hille, DA; Kjeldsen, SE; Lindholm, LH; Okin, PM; Wiik, BP | 1 |
| Álvarez, PM; Amat, AM; Beltrán, FJ; León, EA; Márquez, G; Rodríguez, EM | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Citterio, L; Cooper-DeHoff, RM; Dominiczak, AF; Donner, KM; Gong, Y; Gums, JG; Hedner, T; Hiltunen, TP; Johnson, JA; Kontula, K; Lanzani, C; Manunta, P; McDonough, CW; Melander, O; O'Connell, JR; Padmanabhan, S; Ripatti, S; Saarela, J; Schwartz, GL; Turner, ST; Wahlstrand, B | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, R; Cotsonis, G; Gong, Y; Gums, JG; Johnson, JA; Parekh, V; Schwartz, GL; Turner, ST | 1 |
| Billot, L; Bompoint, S; Bots, ML; Cidambi, R; Field, J; Grobbee, DE; Patel, A; Poulter, N; Prabhakaran, D; Reddy, KS; Rodgers, A; Stanton, A; Thom, S | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Johnson, JA; Karnes, JH; McDonough, CW; O'Connell, JR; Turner, ST | 1 |
| Billot, L; Bompoint, S; Brown, A; Burch, C; Burke, H; Cass, A; Hayman, N; Hillis, GS; Jan, S; Molanus, B; Neal, B; Patel, A; Peiris, D; Rafter, N; Reid, CM; Rodgers, A; Shiel, L; Togni, S; Tonkin, A; Usherwood, T; Webster, R | 1 |
| Arroll, B; Bramley, D; Bryant, L; Bullen, C; Crengle, S; Doughty, RN; Elley, CR; Harwood, M; Jackson, R; Milne, RJ; Parag, V; Rafter, N; Rodgers, A; Selak, V; Wadham, A | 1 |
| Álvarez, PM; Beltrán, FJ; Márquez, G; Rodríguez, EM | 1 |
| Bailey, K; Beitelshees, AL; Boerwinkle, E; Chapman, A; Cooper-DeHoff, RM; Curry, RW; Gong, Y; Gums, JG; Hall, K; Hou, W; Johnson, JA; Moore, MJ; Schmidt, SO; Schwartz, GL; Turner, ST | 1 |
| Abd El-Hady, D; Albishri, HM; Tayeb, RA | 1 |
| Cheng, YQ; Lin, LL; Liu, AJ; Su, DF; Wang, D; Wang, W | 1 |
| Hegazy, MA | 1 |
| Alexander, MR; Burley, JC; Khaled, SA; Roberts, CJ; Yang, J | 1 |
| Carr, M; Damian, DJ; McNamee, R | 1 |
| Kelemen, A; Kónya, Z; Pintye-Hódi, K; Regdon, G; Sipos, B; Sovány, T | 1 |
| Chadha, R; Haneef, J | 1 |
| Atkins, E; Bennett, A; Burke, M; Chalmers, J; Chou, M; Chow, CK; Dehbi, HM; Hillis, G; Hilmer, S; Krum, H; Neal, B; Nelson, M; Patel, A; Peiris, D; Reid, CM; Rodgers, A; Rogers, K; Salam, A; Thakkar, J; Thom, S; Usherwood, T; Vo, K; Webster, R; Woodward, M | 1 |
| Bots, ML; Grobbee, DE; Lafeber, M; Patel, A; Prabhakaran, D; Rodgers, A; Spiering, W; Stanton, A; Thom, S; Visseren, FL; Webster, R | 1 |
| Cheruvu, HS; Devalapalli, MMR; Sampathi, S; Shivakumar, S; Veeravalli, VB; Yertha, T | 1 |
| Cai, B; Cai, T; Gao, Q; Huang, Y; Moinuddin, SM; Ruan, S; Shi, Q | 1 |
| Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Johnson, JA; Kubo, M; Magvanjav, O; McDonough, CW; Pepine, CJ; Tanaka, T; Turner, ST | 1 |
| de Moura Leão, MF; de Oliveira, LFS; Duarte, JA; Machado, MM; Piccoli, JDCE; Sauzen, PD | 1 |
| Bosch, J; Dans, AL; Gamra, H; Gao, P; Joseph, P; Lopez, PC; Lopez-Jaramillo, P; Pais, P; Santoso, A; Talukder, S; Teo, K; Tyrwhitt, J; Xavier, D; Yeates, K; Yusoff, K; Yusuf, S | 1 |
| Abdel Hakiem, AF; Gad El-Hak, ASM; Mahfouz, RM; Mohammed, AAK | 1 |
| Abdulwahab, S; Eissa, MS; Elsonbaty, A; Hassan, WS; Serag, A | 1 |
| Beltrami, G; Catani, M; Cavazzini, A; Chenet, T; Costa, V; Martucci, A; Pasti, L; Precisvalle, N; Sarti, E; Stevanin, C | 1 |
| Bosch, J; Christou, C; Dagenais, G; Dans, A; Gamra, H; Gao, P; Girish, P; Joseph, P; López-Jaramillo, P; McCready, T; Pais, P; Rocha, C; Santoso, A; Talukder, S; Teo, K; Tyrwhitt, J; Xavier, D; Xavier, F; Yeates, K; Yusoff, K; Yusuf, S | 1 |
| Jayswal, K; Prajapati, PB; Shah, SA | 1 |
| Cooper-DeHoff, RM; Dasa, O; Gong, Y; Handberg, E; Howard, G; Pepine, CJ; Smith, SM | 1 |
| Al-Tannak, NF; Hemdan, A; Mohamed, EH | 1 |
7 review(s) available for atenolol and hydrochlorothiazide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Enalapril; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Meta-Analysis as Topic; Nifedipine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Time Factors; Ventricular Dysfunction, Left | 2002 |
Combination therapy as first-line treatment of arterial hypertension.
Topics: Antihypertensive Agents; Atenolol; Captopril; Diltiazem; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Prazosin; Treatment Outcome | 2002 |
A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke.
Topics: Antihypertensive Agents; Aspirin; Atenolol; Cardiovascular Diseases; Drug Combinations; Humans; Hydrochlorothiazide; Hypolipidemic Agents; Platelet Aggregation Inhibitors; Primary Prevention; Ramipril; Simvastatin; Stroke | 2012 |
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
129 trial(s) available for atenolol and hydrochlorothiazide
| Article | Year |
|---|---|
Combination therapy with saluretics and atenolol in essential hypertension. Effects on blood pressure, electrolytes and uric acid.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bendroflumethiazide; Chlorthalidone; Diuretics; Drug Evaluation; Drug Therapy, Combination; Electrolytes; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Mefruside; Middle Aged; Propanolamines; Uric Acid | 1979 |
Quality of life in hypertensives treated with atenolol or captopril: a double-blind crossover trial.
Topics: Adult; Aged; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Quality of Life | 1992 |
Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study.
Topics: Aged; Aged, 80 and over; Amiloride; Atenolol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Pindolol; Prospective Studies; Treatment Outcome | 1992 |
Haemodynamic findings and response rates to beta-blocker--and diuretic monotherapy in mild and moderate hypertension. A one year randomized, double blind study in 100 men.
Topics: Adult; Amiloride; Atenolol; Blood Pressure; Cardiac Output; Drug Combinations; Heart Rate; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Ultrasonography; Vascular Resistance | 1992 |
Which anti-hypertensive to add to a beta-blocker: ACE inhibitor or diuretic?
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Lisinopril; Male; Middle Aged | 1992 |
Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitors; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male | 1992 |
Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
Topics: Aged; Amiloride; Atenolol; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Sex Factors; Single-Blind Method | 1992 |
Changes in left ventricular dimensions and systolic function in 100 mildly hypertensive men during one year's treatment with atenolol vs. hydrochlorothiazide and amiloride (Moduretic): a double-blind, randomized study.
Topics: Adult; Aged; Atenolol; Cardiomegaly; Double-Blind Method; Echocardiography; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Systole; Time Factors | 1992 |
Are there differences in the blood-pressure-lowering effect of atenolol vs. hydrochlorothiazide + amiloride (Moduretic) when assessed by standard clinic recordings vs. 24-h ambulatory monitoring?
Topics: Adult; Amiloride; Atenolol; Blood Pressure; Blood Pressure Determination; Double-Blind Method; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Monitoring, Physiologic | 1992 |
Lipid profile in 100 men with moderate hypertension treated for 1 year with atenolol or hydrochlorothiazide plus amiloride: a double-blind, randomized study.
Topics: Adult; Amiloride; Apoproteins; Atenolol; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Infant, Newborn; Lipids; Lipoproteins; Male; Middle Aged | 1992 |
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1991 |
Antihypertensive and metabolic effects of single and combined atenolol regimens.
Topics: Atenolol; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Triamterene | 1992 |
Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Carbazoles; Carvedilol; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins; Male; Middle Aged; Propanolamines; Randomized Controlled Trials as Topic; Triglycerides | 1990 |
Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atenolol; Blood Pressure; Carbazoles; Carvedilol; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Patient Compliance; Propanolamines; Randomized Controlled Trials as Topic | 1990 |
Hypertension in the elderly: a study of a combination of atenolol, hydrochlorothiazide and amiloride hydrochloride.
Topics: Aged; Amiloride; Atenolol; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male | 1990 |
Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril.
Topics: Analysis of Variance; Atenolol; Blood Pressure; Cognition; Depression; Diuretics; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Memory; Middle Aged; Neuropsychological Tests; Quality of Life; Safety | 1990 |
Analysis of time trends, individual subject responses and background variation in crossover factorial studies with antihypertensive drugs.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension | 1990 |
Efficacy and safety of combinations of nitrendipine, atenolol, and hydrochlorothiazide in black hypertensive patients.
Topics: Atenolol; Black People; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Nitrendipine | 1990 |
[Perindopril: first-line treatment of arterial hypertension].
Topics: Adolescent; Adult; Aged; Amiloride; Antihypertensive Agents; Atenolol; Captopril; Clinical Trials as Topic; Diuretics; Drug Evaluation; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Random Allocation | 1989 |
[Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiac Output; Cardiac Volume; Cardiomegaly; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Gallopamil; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle Aged; Nifedipine | 1989 |
The effect of chronic antihypertensive therapy on the index of left ventricular mass in patients with essential hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiac Volume; Clinical Trials as Topic; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Prazosin; Random Allocation; Reserpine | 1989 |
[Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy].
Topics: Adult; Aged; Aged, 80 and over; Amiloride; Atenolol; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Ketanserin; Male; Middle Aged | 1989 |
[Enalapril, atenolol and hydrochlorothiazide in mild or moderate hypertension. A comparative multicenter trial in general practice in Norway].
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Norway; Random Allocation | 1987 |
Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions.
Topics: Angiotensin II; Atenolol; Atrial Natriuretic Factor; Double-Blind Method; Drug Therapy, Combination; Enalapril; Factor Analysis, Statistical; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Random Allocation; Renin | 1987 |
Treating the older hypertensive: beta-blocker or diuretic?
Topics: Adrenergic beta-Antagonists; Aged; Amiloride; Atenolol; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Random Allocation; Time Factors | 1985 |
Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway.
Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Headache; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Muscle Hypotonia; Potassium; Random Allocation; Time Factors; Uric Acid | 1986 |
Enalapril, atenolol, and hydrochlorothiazide in hypertension.
Topics: Atenolol; Clinical Trials as Topic; Double-Blind Method; Enalapril; Humans; Hydrochlorothiazide; Hypertension | 1986 |
Swedish trial in old patients with hypertension. A prospective multicentre study in Swedish primary health care.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiloride; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Pindolol; Prospective Studies; Random Allocation; Sweden | 1986 |
The long-term antihypertensive effects of prazosin and atenolol.
Topics: Atenolol; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Prazosin; Time Factors | 1989 |
The antihypertensive effects of doxazosin: a clinical overview.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Kinetics; Male; Metoprolol; Middle Aged; Nadolol; Prazosin; Propanolamines; Random Allocation; Risk; Triglycerides | 1986 |
Enalapril maleate and atenolol combined with hydrochlorothiazide in moderate to severe essential hypertension.
Topics: Adult; Aged; Atenolol; Clinical Trials as Topic; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Random Allocation | 1985 |
Enalapril in moderate to severe hypertension: a comparison with atenolol.
Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Creatinine; Drug Evaluation; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Random Allocation; Urea | 1986 |
A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Black People; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; India; Lisinopril; Male; Random Allocation; South Africa | 1987 |
A comparison of captopril and atenolol in addition to hydrochlorothiazide for the treatment of hypertension.
Topics: Adult; Atenolol; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 1988 |
A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
Topics: Adult; Aged; Atenolol; Drug Combinations; Family Practice; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation; Triamterene | 1987 |
Placebo controlled double-blind randomised cross-over trial of atenolol, hydrochlorothiazide and amiloride, and the combination (Kalten) in patients over 60 years of age.
Topics: Aged; Amiloride; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Random Allocation | 1986 |
Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial.
Topics: Adult; Atenolol; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins; Male; Middle Aged; Prospective Studies; Random Allocation; Triglycerides | 1987 |
Atenolol vs. amiloride-hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind, crossover, placebo-controlled study.
Topics: Adult; Aged; Amiloride; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pulse; Random Allocation | 1987 |
Beta-blocker versus diuretic for control of the blood pressure response to stress in hypertensive patients.
Topics: Adult; Amiloride; Atenolol; Chronic Disease; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Physical Exertion; Stress, Psychological | 1986 |
Long-term effects of captopril and atenolol in essential hypertension.
Topics: Adult; Aged; Atenolol; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proline; Time Factors | 1985 |
[Comparison of hypotensive effectiveness of propranolol and atenolol in combined treatment of primary hypertension].
Topics: Adult; Atenolol; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol | 1985 |
Prazosin once or twice daily?
Topics: Adult; Aged; Amiloride; Atenolol; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Posture; Prazosin; Propranolol; Quinazolines | 1985 |
[Blood pressure during isometric and dynamic exercise under long-term antihypertensive treatment with beta receptor blockaders and diuretics].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Diuretics; Exercise Test; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isometric Contraction; Male; Middle Aged; Muscle Contraction; Physical Exertion; Random Allocation; Time Factors | 1983 |
The effects of two combinations of a beta-blocker and a diuretic on diuresis in normal subjects.
Topics: Adult; Atenolol; Chlorthalidone; Clinical Trials as Topic; Diuresis; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Male; Potassium; Sodium; Sotalol; Uric Acid; Urine | 1984 |
Captopril or atenolol in essential hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proline; Random Allocation | 1983 |
Comparison of hydrochlorothiazide and atenolol as initial treatment in uncomplicated hypertension.
Topics: Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Female; Half-Life; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1984 |
The influence of beta blockers on cardiovascular reactivity and Type A behavior pattern in hypertensives.
Topics: Amiloride; Atenolol; Blood Pressure; Coronary Disease; Drug Therapy, Combination; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Personality | 1983 |
[The effect of beta receptor blockers and diuretics on blood pressure reactivity].
Topics: Adult; Amiloride; Atenolol; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Stress, Psychological | 1983 |
Captopril and atenolol combined with hydrochlorothiazide in essential hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proline; Propanolamines; Renin-Angiotensin System | 1982 |
Effects of beta-blockers on type-A coronary-prone behaviour.
Topics: Amiloride; Atenolol; Blood Pressure; Coronary Disease; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Personality; Propanolamines; Random Allocation | 1982 |
Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; France; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Italy; Male; Middle Aged; Nifedipine; United Kingdom | 1993 |
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Fibrinogen; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Potassium; Triglycerides; Uric Acid | 1995 |
Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Asthenia; Atenolol; Biphenyl Compounds; Cough; Dizziness; Double-Blind Method; Fatigue; Felodipine; Female; Headache; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Placebos; Respiratory Tract Infections; Safety; Tetrazoles | 1995 |
Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Double-Blind Method; Drug Combinations; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pulse; Safety; Single-Blind Method; Triglycerides | 1994 |
Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderly.
Topics: Aged; Aged, 80 and over; Amiloride; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Nifedipine; Patient Satisfaction; Treatment Outcome | 1994 |
MRC trial of treatment in elderly hypertensives.
Topics: Aged; Amiloride; Atenolol; Blood Pressure; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male | 1993 |
Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
Topics: Aged; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Potassium; Prospective Studies | 1994 |
Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group.
Topics: Adult; Aged; Atenolol; Cholesterol; Cholesterol, HDL; Coronary Disease; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors | 1993 |
Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Monitoring, Physiologic; Quinapril; Tetrahydroisoquinolines; Triglycerides | 1993 |
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Age Factors; Aged; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Captopril; Clonidine; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin | 1993 |
Left ventricular end-diastolic dimensions measured at the P wave and Q wave during a randomized, double-blind one-year follow-up study comparing the effect of atenolol vs. hydrochlorothiazide + amiloride on blood pressure in men with mild to moderate hype
Topics: Adult; Amiloride; Atenolol; Diastole; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Heart Rate; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Myocardium | 1993 |
Losartan potassium as initial therapy in patients with severe hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 1995 |
A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population.
Topics: Aged; Amiloride; Antihypertensive Agents; Atenolol; Cognition Disorders; Dementia; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Longitudinal Studies; Male; Neuropsychological Tests; Risk Factors; Smoking | 1996 |
'Hypertension resistant to two-drug treatment' is a useful criterion to select patients for angiography: the 'Dutch Renal Artery Stenosis Intervention Cooperative' (DRASTIC) study.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiography; Antihypertensive Agents; Atenolol; Drug Resistance, Multiple; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Selection; Radionuclide Imaging; Renal Artery Obstruction | 1996 |
The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Captopril; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol; Quality of Life; Sodium Chloride Symporter Inhibitors; Surveys and Questionnaires | 1996 |
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Safety; Verapamil | 1997 |
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Captopril; Clonidine; Cohort Studies; Diltiazem; Diuretics; Double-Blind Method; Echocardiography; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Organ Size; Prazosin; Prevalence; Risk Factors; Sodium Chloride Symporter Inhibitors; Treatment Outcome; United States; United States Department of Veterans Affairs | 1997 |
Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nitrendipine; Sex Factors; Treatment Outcome | 1997 |
Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors | 1997 |
Hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment. Influence on LVH, proteinuria and metabolic parameters. The HANE Trial Research Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood; Calcium Channel Blockers; Diuretics; Double-Blind Method; Enalapril; Humans; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Middle Aged; Nitrendipine; Single-Blind Method; Sodium Chloride Symporter Inhibitors | 1997 |
Effect of hypotensive drugs on the circadian blood pressure pattern in essential hypertension: a comparative study.
Topics: Adrenergic beta-Antagonists; Aged; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Nifedipine; Perindopril; Sodium Chloride Symporter Inhibitors | 1997 |
Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Diuretics; Double-Blind Method; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Sleep Apnea Syndromes; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1998 |
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.
Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Cerebrovascular Disorders; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Myocardial Infarction; Verapamil | 1998 |
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy.
Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 1999 |
Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Clonidine; Diltiazem; Diuretics; Double-Blind Method; Hospitals, Veterans; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Potassium; Prazosin; Time Factors; Treatment Outcome; United States | 1999 |
The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Enalapril; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Sleep Apnea Syndromes; Sodium Chloride Symporter Inhibitors | 1999 |
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diuretics; Drug Interactions; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Research Design; Tetrazoles; Valine; Valsartan | 1999 |
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Single-Blind Method; Sleep Apnea, Obstructive; Sodium Chloride Symporter Inhibitors | 2000 |
The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Systole; Treatment Outcome | 2000 |
Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Benzimidazoles; Benzoates; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Telmisartan | 2001 |
Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes.
Topics: Aged; Aged, 80 and over; Amiloride; Antihypertensive Agents; Atenolol; Blood Pressure; Carotid Artery, Common; Carotid Stenosis; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; France; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Risk Factors; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2001 |
Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Electrocardiography, Ambulatory; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome; Verapamil | 2001 |
Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cohort Studies; Drug Resistance; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension, Renal; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiography; Renal Artery; Renal Artery Obstruction | 2001 |
Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Clonidine; Diastole; Diltiazem; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Pressure; Pulse; Randomized Controlled Trials as Topic; Systole; Time Factors; Treatment Outcome | 2001 |
Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Arteries; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Endothelium, Vascular; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Nitroprusside; Receptors, Angiotensin; Sensitivity and Specificity; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome; Vascular Resistance | 2002 |
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
Topics: Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Stroke; Systole; Treatment Outcome | 2002 |
Different drug classes have variable effects on blood pressure depending on the time of day.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cross-Over Studies; Felodipine; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Perindopril | 2003 |
Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Remission Induction; Single-Blind Method | 2003 |
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Topics: Antihypertensive Agents; Apolipoproteins; Atenolol; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Electrolytes; Female; Glucose Tolerance Test; Humans; Hydrochlorothiazide; Hypertension; Insulin; Lipids; Male; Metabolic Syndrome; Middle Aged; Prospective Studies | 2003 |
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Verapamil | 2003 |
Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antioxidants; Atenolol; Benzimidazoles; Benzoates; DNA Damage; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Oxidative Stress; Telmisartan; Treatment Outcome | 2004 |
[The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Combined Modality Therapy; Diet, Vegetarian; Diuretics; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Sodium Chloride Symporter Inhibitors | 2005 |
Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Obesity; Sodium Chloride Symporter Inhibitors; Tetrazoles; Valine; Valsartan | 2005 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Body Mass Index; Calcium Channel Blockers; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hispanic or Latino; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertrophy, Left Ventricular; Indoles; Ischemic Attack, Transient; Male; Myocardial Revascularization; Residence Characteristics; Risk Factors; Stroke; Systole; Verapamil | 2006 |
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Blood Pressure; Diastole; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Pulse; Systole; Treatment Outcome | 2007 |
Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension.
Topics: Adult; Aged; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Atenolol; Biomarkers; Blood Pressure; Cytokines; Diastole; Female; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Systole; Ultrasonography | 2007 |
Sex differences in blood pressure response to antihypertensive therapy in Chinese patients with hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Asian People; Atenolol; Blood Pressure; Captopril; China; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Prospective Studies; Sex Factors | 2008 |
The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atenolol; Capsules; Cardiovascular Agents; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Combinations; Drug Costs; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Platelet Aggregation Inhibitors; Primary Prevention; Ramipril; Research Design; Secondary Prevention; Simvastatin; Treatment Outcome | 2009 |
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Ambulatory; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Middle Aged; Pharmacogenetics; Research Design; Young Adult | 2009 |
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Atenolol; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Middle Aged; Platelet Aggregation Inhibitors; Ramipril; Risk Factors; Risk Reduction Behavior; Simvastatin; Treatment Outcome | 2009 |
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.
Topics: Adult; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; White People | 2009 |
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Verapamil | 2007 |
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Diabetes Mellitus; Drug Therapy, Combination; Fasting; Female; Humans; Hydrochlorothiazide; Hyperglycemia; Hypertension; Hypertriglyceridemia; Hyperuricemia; Lipoproteins, HDL; Male; Metabolic Diseases; Middle Aged; Obesity, Abdominal; Outcome Assessment, Health Care; Young Adult | 2010 |
Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Treatment Outcome | 2010 |
Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Antihypertensive Agents; Area Under Curve; Aspirin; Atenolol; Biological Availability; Capsules; Cardiovascular Diseases; Chromatography, Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Humans; Hydrochlorothiazide; Hypolipidemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Ramipril; Risk Factors; Simvastatin; Tandem Mass Spectrometry; Young Adult | 2010 |
How to avoid discontinuation of antihypertensive treatment: The experience in São Paulo, Brazil.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Clinical Protocols; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Medication Adherence; Middle Aged; Telephone | 2010 |
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides; Uric Acid | 2012 |
The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Hypokalemia; Losartan; Male; Prospective Studies; Ultrasonography | 2012 |
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hydrochlorothiazide; Linear Models; Male; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Sample Size; Signal-To-Noise Ratio; Treatment Outcome | 2012 |
A double-blind, placebo-controlled, crossover trial comparing the effects of amiloride and hydrochlorothiazide on glucose tolerance in patients with essential hypertension.
Topics: Adult; Aged; Amiloride; Atenolol; Blood Glucose; Blood Pressure Determination; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Risk Assessment; Severity of Illness Index; Treatment Outcome; United Kingdom | 2012 |
Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators.
Topics: Administration, Oral; Aged; Analysis of Variance; Antihypertensive Agents; Aspirin; Atenolol; Biomarkers; Blood Pressure; Capsules; Cardiovascular Diseases; Cholesterol, LDL; Creatinine; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; India; Male; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Potassium; Ramipril; Risk Assessment; Risk Factors; Simvastatin; Tablets; Time Factors; Treatment Outcome | 2012 |
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.
Topics: Aged; Antihypertensive Agents; Atenolol; Diabetes Mellitus; Fasting; Female; Glucose; Haplotypes; Humans; Hydrochlorothiazide; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Potassium Channels, Inwardly Rectifying; Prospective Studies; Verapamil | 2013 |
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
Topics: Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Female; Genetic Loci; Genetic Predisposition to Disease; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; White People | 2012 |
In-treatment HDL cholesterol levels and development of new diabetes mellitus in hypertensive patients: the LIFE Study.
Topics: Aged; Antihypertensive Agents; Atenolol; Cholesterol, HDL; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypertension; Hypertrophy, Left Ventricular; Incidence; Losartan; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Risk Factors | 2013 |
Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; White People | 2014 |
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Female; Humans; Hydrochlorothiazide; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Simvastatin; Treatment Outcome | 2013 |
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Blood Glucose; Drug Therapy, Combination; Fasting; Female; Homeodomain Proteins; Humans; Hydrochlorothiazide; Hyperglycemia; Hypertension; Linear Models; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Risk Factors; Tumor Suppressor Proteins; White People | 2014 |
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Atenolol; Australia; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Drug Combinations; Drugs, Generic; Female; General Practice; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lisinopril; Male; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Primary Prevention; Prospective Studies; Risk Factors; Simvastatin; Sodium Chloride Symporter Inhibitors; Tablets; Time Factors; Treatment Outcome | 2015 |
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Medication Adherence; Middle Aged; New Zealand; Primary Health Care; Regression Analysis; Risk Factors; Simvastatin; Young Adult | 2014 |
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antihypertensive Agents; Atenolol; Blood Glucose; Cohort Studies; Diuretics; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Hydrochlorothiazide; Hyperglycemia; Hypertension; Male; Middle Aged; Models, Biological; Risk; ROC Curve; United States | 2014 |
Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Age Factors; Aged; Amiloride; Antihypertensive Agents; Atenolol; Biomarkers; Blood Glucose; Body Weight; Cholesterol; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Intention to Treat Analysis; Linear Models; Male; Potassium; Single-Blind Method; Sodium; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; United Kingdom; Urea; Uric Acid | 2016 |
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Aspirin; Atenolol; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Drug Substitution; Europe; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Risk Assessment; Risk Factors; Simvastatin; Tablets; Time Factors; Treatment Outcome | 2017 |
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aldehyde Dehydrogenase 1 Family; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Chi-Square Distribution; Drug Combinations; Drug Resistance; Female; Florida; Genome-Wide Association Study; Georgia; Humans; Hydrochlorothiazide; Hypertension; Indoles; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pharmacogenetics; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Prospective Studies; Retinal Dehydrogenase; Risk Factors; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Vasodilator Agents; Verapamil; Young Adult | 2017 |
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Combinations; Female; Global Health; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Primary Prevention; Ramipril; Retrospective Studies; Simvastatin | 2018 |
Polypill with or without Aspirin in Persons without Cardiovascular Disease.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Incidence; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Simvastatin | 2021 |
99 other study(ies) available for atenolol and hydrochlorothiazide
| Article | Year |
|---|---|
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Topics: Humans; Intestinal Absorption; Jejunum; Models, Biological; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship | 1998 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
Topics: Adult; Angiotensin II; Atenolol; Blood Pressure; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Plasma Volume; Propanolamines; Propranolol; Renin; Saralasin; Sodium | 1979 |
Absorption of polar drugs following caecal instillation in healthy volunteers.
Topics: Adult; Atenolol; Biological Availability; Cecum; Cimetidine; Colon; Female; Furosemide; Humans; Hydrochlorothiazide; Ileum; Instillation, Drug; Intestinal Absorption; Jejunum; Male; Perfusion; Pharmacokinetics; Salicylates; Salicylic Acid | 1992 |
Effects of a new dihydropyridine derivative, FRC-8653, on blood pressure in conscious spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Dihydropyridines; Heart Rate; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR | 1992 |
The influence of gastrointestinal transit on drug absorption in healthy volunteers.
Topics: Administration, Oral; Adult; Atenolol; Codeine; Female; Furosemide; Gastric Emptying; Gastrointestinal Transit; Humans; Hydrochlorothiazide; Intestinal Absorption; Male; Metoclopramide; Middle Aged; Salicylates; Salicylic Acid | 1992 |
Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers.
Topics: Adult; Atenolol; Furosemide; Gastrointestinal Transit; Humans; Hydrochlorothiazide; Intestinal Absorption; Mannitol; Osmosis; Salicylates; Salicylic Acid | 1992 |
Stress and sodium hypertension in baboons: neuroendocrine and pharmacotherapeutic assessments.
Topics: Animals; Atenolol; Atrial Natriuretic Factor; Creatinine; Dopamine; Epinephrine; Hydrochlorothiazide; Hydrocortisone; Hypertension; Male; Norepinephrine; Osmolar Concentration; Papio; Renin; Sodium; Sodium, Dietary; Stress, Physiological; Vasopressins | 1991 |
[Enalapril, atenolol and hydrochlorothiazide in mild and moderate hypertension].
Topics: Atenolol; Enalapril; Humans; Hydrochlorothiazide; Hypertension | 1988 |
[Combination of enalapril with diuretics in the treatment of arterial hypertension].
Topics: Atenolol; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension | 1986 |
[Validity of a fixed atenolol/hydrochlorothiazide/amiloride combination (100/25/2.5 mg) in the therapy of essential arterial hypertension].
Topics: Adolescent; Adult; Amiloride; Atenolol; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1988 |
A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients.
Topics: Adult; Aged; Aging; Amiloride; Atenolol; Blood Pressure; Drug Combinations; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Kinetics | 1987 |
Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Diuretics; Female; Furosemide; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol; Systole | 1983 |
[Combined effect of hydrochlorothiazide and atenolol in antihypertensive therapy of 42 patients].
Topics: Adult; Atenolol; Blood Pressure; Drug Therapy, Combination; Electrolytes; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male | 1983 |
[Efficacy of the association of atenolol with an amiloride-hydrochlorothiazide combination in the treatment of persistent arterial hypertension].
Topics: Adult; Aged; Amiloride; Atenolol; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pyrazines; Retrospective Studies | 1984 |
[Antihypertensives and the prevention of development of genetic hypertension in the hypertensive SHR rat].
Topics: Animals; Antihypertensive Agents; Atenolol; Captopril; Cardiomegaly; Dihydralazine; Dose-Response Relationship, Drug; Hydrochlorothiazide; Hypertension; Male; Nicardipine; Nifedipine; Prazosin; Rats; Rats, Inbred Strains; Time Factors; Vasodilator Agents | 1980 |
Effects of hydrochlorothiazide combined with amiloride in atenolol-resistant hypertensive patients.
Topics: Adult; Amiloride; Atenolol; Blood Pressure; Drug Combinations; Drug Resistance; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Pyrazines | 1983 |
Pressure and humoral changes induced by atenolol and hydrochlorothiazide + amiloride, alone and in free combination. A comparative between-patient study.
Topics: Adult; Amiloride; Atenolol; Blood Pressure; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Male; Middle Aged; Potassium; Pyrazines | 1983 |
Withdrawal of antihypertensive drugs in mild hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pindolol; Time Factors | 1981 |
[Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
Topics: Adult; Aged; Amiloride; Atenolol; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propanolamines; Pyrazines; Timolol | 1981 |
Implementation of local guidelines for cost-effective management of hypertension. A trial of the firm system.
Topics: Antihypertensive Agents; Atenolol; Cost-Benefit Analysis; Female; Health Education; Hospitals, Veterans; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Ohio; Practice Guidelines as Topic | 1996 |
Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Topics: Atenolol; Biological Transport; Caco-2 Cells; Cell Division; Cell Membrane Permeability; Cimetidine; HT29 Cells; Humans; Hydrochlorothiazide; Intestinal Absorption; Mannitol; Ranitidine; Tritium | 1996 |
Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Hydrochlorothiazide; Male; Nitrobenzenes; Piperazines; Prazosin; Rats; Rats, Inbred SHR; Renin; Sodium Chloride Symporter Inhibitors; Tetrazoles | 1996 |
Electromechanical dissociation 48 hours after atenolol overdose: usefulness of calcium chloride.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Calcium Chloride; Drug Overdose; Electrocardiography; Female; Gastric Lavage; Heart Conduction System; Humans; Hydrochlorothiazide; Respiration, Artificial; Suicide, Attempted | 1998 |
Simultaneous determination of amiloride HCl, hydrochlorothiazide and atenolol in combined formulations by derivative spectroscopy.
Topics: Amiloride; Atenolol; Drug Combinations; Hydrochlorothiazide; Regression Analysis; Spectrum Analysis | 1998 |
Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Atenolol; Creatinine; Diuretics; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hydrochlorothiazide; Kidney; Kidney Function Tests; Male; Nootropic Agents; Pharmacokinetics; Piracetam; Triamterene | 1999 |
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Confidence Intervals; Databases as Topic; Diuretics; Drug Compounding; Evaluation Studies as Topic; Female; Humans; Hydrochlorothiazide; Logistic Models; Male; Metolazone; Metoprolol; Myocardial Infarction; Odds Ratio; Ontario; Propranolol; Retrospective Studies; Sex Factors; Sodium Chloride Symporter Inhibitors; Timolol | 1999 |
The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Fasting; Female; Humans; Hydrochlorothiazide; Hypertension; Islam; Male; Middle Aged; Nifedipine; Religion and Medicine; Sleep; Verapamil | 2001 |
Monitoring one-year compliance to antihypertension medication in the Seychelles.
Topics: Adult; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Cross-Sectional Studies; Drug Monitoring; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Longitudinal Studies; Male; Middle Aged; Office Visits; Patient Compliance; Self Administration; Seychelles | 2002 |
[LIFE study proves preventive action. With losartan to do even more against stroke].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Diabetes Complications; Double-Blind Method; Electrocardiography; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Time Factors | 2003 |
LIFE: losartan versus atenolol.
Topics: Antihypertensive Agents; Atenolol; Comorbidity; Death, Sudden, Cardiac; Diabetes Mellitus; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
Chemometric determination of amiloride hydrochloride, atenolol, hydrochlorothiazide and timolol maleate in synthetic mixtures and pharmaceutical formulations.
Topics: Amiloride; Atenolol; Chemistry, Pharmaceutical; Hydrochlorothiazide; Least-Squares Analysis; Spectrophotometry, Ultraviolet; Timolol | 2004 |
Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
Topics: Adult; Aging; Antihypertensive Agents; Atenolol; Case-Control Studies; Cohort Studies; Drug Prescriptions; Female; Humans; Hydrochlorothiazide; Hypertension; Insurance Claim Review; Insurance, Pharmaceutical Services; Lisinopril; Male; Middle Aged; Patient Compliance; Prospective Studies; Time Factors | 2005 |
A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients.
Topics: Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chi-Square Distribution; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Treatment Outcome; Verapamil | 2005 |
Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer.
Topics: Albuterol; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Atenolol; Cisplatin; Creatinine; Demography; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydrochlorothiazide; Incidence; Kidney Diseases; Male; Middle Aged; Retrospective Studies | 2006 |
Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease.
Topics: Aged; Albuminuria; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Cohort Studies; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enalapril; Fibrinolysis; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Plasminogen Activator Inhibitor 1; Risk Factors; Time Factors; Tissue Plasminogen Activator | 2006 |
Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Aorta; Atenolol; Baroreflex; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Kidney Diseases; Male; Nifedipine; Rats; Rats, Inbred SHR; Tetrazoles | 2006 |
[Plus point -- risk reduction].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Losartan; Placebos; Risk; Risk Factors; Stroke; Time Factors | 2006 |
Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Heart Rate; Hydrochlorothiazide; Hypertension; Losartan; Male; Ramipril; Rats; Rats, Wistar; Sympathetic Nervous System | 2006 |
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler | 2007 |
The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Therapy, Combination; Fasting; Female; Humans; Hydrochlorothiazide; Hypertension; Islam; Male; Middle Aged; Nifedipine; Religion and Medicine; Verapamil | 2008 |
Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Black People; Coronary Artery Disease; Databases, Factual; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Stroke; United States; Verapamil | 2008 |
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products.
Topics: Aspirin; Atenolol; Atorvastatin; Cardiovascular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Heptanoic Acids; Hydrochlorothiazide; Lisinopril; Pravastatin; Pyrroles; Simvastatin; Spectrometry, Mass, Electrospray Ionization | 2008 |
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Production and secretion of adiponectin from 3T3-L1 adipocytes: comparison of antihypertensive drugs.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Captopril; Hydrochlorothiazide; Losartan; Mice; Nifedipine; RNA, Messenger; Telmisartan | 2009 |
Effect of antihypertensive drug therapy on short-term heart rate variability in newly diagnosed essential hypertension.
Topics: Adult; Amlodipine; Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sinoatrial Node | 2010 |
INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Coronary Artery Disease; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Randomized Controlled Trials as Topic; Verapamil | 2009 |
Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity.
Topics: Adrenergic beta-Antagonists; Atenolol; Diabetes Mellitus; Diuretics; Drug Therapy, Combination; Fasting; Humans; Hydrochlorothiazide; Hyperglycemia; Hypertension; Hypertriglyceridemia; Hyperuricemia; Lipoproteins, HDL; Metabolic Diseases; Obesity, Abdominal | 2010 |
Malignancy-associated multicentric reticulohistiocytosis.
Topics: Antihypertensive Agents; Antineoplastic Agents; Arthralgia; Atenolol; Combined Modality Therapy; Drug Therapy, Combination; Fatigue; Female; Hand; Histiocytosis, Non-Langerhans-Cell; Humans; Hydrochlorothiazide; Hypertension; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasms, Squamous Cell; Prednisone; Radiography; Weight Loss | 2011 |
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Randomized Controlled Trials as Topic | 2010 |
Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.
Topics: Antihypertensive Agents; Atenolol; Captopril; Cardiovascular Diseases; Cost of Illness; Developing Countries; Health Services Accessibility; Humans; Hydrochlorothiazide; Losartan; Nifedipine; World Health Organization | 2010 |
Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol?
Topics: Antihypertensive Agents; Atenolol; Electrocardiography; Humans; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Losartan; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Occurrence and removal of pharmaceuticals and hormones through drinking water treatment.
Topics: Atenolol; Carbamazepine; Hormones; Hydrochlorothiazide; Ozone; Pharmaceutical Preparations; Phenytoin; Sotalol; Water Pollutants, Chemical; Water Purification; Water Supply | 2011 |
Simultaneous spectrophotometric estimation of Hydrochlorothiazide, Atenolol and Losartan potassium in tablet dosage form.
Topics: Antihypertensive Agents; Atenolol; Calibration; Hydrochlorothiazide; Losartan; Spectrophotometry, Ultraviolet; Tablets | 2009 |
Anti-inflammatory effects of anti-hypertensive agents: influence on interleukin-1β secretion by peripheral blood polymorphonuclear leukocytes from patients with essential hypertension.
Topics: Adult; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Captopril; Case-Control Studies; Female; Humans; Hydrochlorothiazide; Hypertension; In Vitro Techniques; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Losartan; Male; Middle Aged; Neutrophils | 2011 |
An economic evaluation of antihypertensive therapies based on clinical trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Costs; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Randomized Controlled Trials as Topic | 2012 |
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
Topics: Adult; Antihypertensive Agents; Atenolol; Black or African American; Blood Pressure; Chromosomes, Human, Pair 12; Clinical Trials as Topic; Female; Gene Expression Regulation; Genome-Wide Association Study; Genotype; Haplotypes; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Polymorphism, Single Nucleotide; Transcription Factors; White People | 2013 |
Effects of potassium-sparing versus thiazide diuretics on glucose tolerance: new data on an old topic.
Topics: Amiloride; Atenolol; Blood Glucose; Female; Humans; Hydrochlorothiazide; Hypertension; Male | 2012 |
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Female; G-Protein-Coupled Receptor Kinase 4; Genotype; Haplotypes; Humans; Hydrochlorothiazide; Hypertension; Male; Pharmacogenetics; Polymorphism, Single Nucleotide; Treatment Outcome; Verapamil | 2012 |
Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cell Dedifferentiation; Cell Line; Chemokine CCL20; Cytoprotection; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Inflammation; Isoantibodies; Macrophages; Male; Mice; Nephrectomy; Podocytes; Proteinuria; Rats; Rats, Wistar; Receptors, CCR6; Receptors, Platelet-Derived Growth Factor; RNA Interference; RNA, Messenger; Telmisartan; Time Factors; Transfection | 2013 |
Factors affecting drug adsorption on beta zeolites.
Topics: Adsorption; Atenolol; Hydrochlorothiazide; Hydrophobic and Hydrophilic Interactions; Ketoprofen; Osmolar Concentration; Thermogravimetry; X-Ray Diffraction; Zeolites | 2013 |
Mechanism considerations for photocatalytic oxidation, ozonation and photocatalytic ozonation of some pharmaceutical compounds in water.
Topics: Adsorption; Atenolol; Environmental Restoration and Remediation; Hydrochlorothiazide; Hydrogen-Ion Concentration; Ofloxacin; Oxidation-Reduction; Oxygen; Ozone; Photochemical Processes; Semiconductors; Titanium; Trimethoprim; Ultraviolet Rays; Water Pollutants, Chemical | 2013 |
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Chromosomes, Human, Pair 17; Diuretics; Female; Genome-Wide Association Study; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Polymorphism, Single Nucleotide; Protein Kinase C-alpha; Transcription Factors | 2013 |
Solar photocatalytic ozonation of a mixture of pharmaceutical compounds in water.
Topics: Atenolol; Biodegradation, Environmental; Catalysis; Hydrochlorothiazide; Models, Chemical; Molecular Structure; Ofloxacin; Oxidation-Reduction; Ozone; Pharmaceutical Preparations; Photolysis; Sunlight; Titanium; Trimethoprim; Wastewater; Water Pollutants, Chemical; Water Purification | 2014 |
Cyclodextrin Micellar LC for Direct Selective Analysis of Combined Dosage Drugs in Urine.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Antihypertensive Agents; Atenolol; beta-Cyclodextrins; Bisoprolol; Chlorthalidone; Chromatography, Liquid; Drug Combinations; Humans; Hydrochlorothiazide; Limit of Detection; Male; Micelles; Sodium Dodecyl Sulfate | 2015 |
Long-term treatment of clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impairs the sexual function in male spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Clonidine; Drug Administration Schedule; Enalapril; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR; Sexual Dysfunction, Physiological | 2015 |
A novel pure component contribution algorithm (PCCA) for extracting components' contribution from severely overlapped signals; an application to UV-spectrophotometric data.
Topics: Acetaminophen; Algorithms; Amiloride; Atenolol; Capsules; Hydrochlorothiazide; Ibuprofen; Spectrophotometry, Ultraviolet; Tablets | 2015 |
3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles.
Topics: Aspirin; Atenolol; Delayed-Action Preparations; Drug Combinations; Drug Liberation; Excipients; Hydrochlorothiazide; Powder Diffraction; Pravastatin; Printing, Three-Dimensional; Ramipril; Solubility; Spectroscopy, Fourier Transform Infrared; Tablets; X-Ray Diffraction | 2015 |
Physicochemical characterisation and investigation of the bonding mechanisms of API-titanate nanotube composites as new drug carrier systems.
Topics: Atenolol; Calorimetry, Differential Scanning; Diclofenac; Diltiazem; Drug Carriers; Drug Liberation; Hydrochlorothiazide; Microscopy, Electron, Scanning; Nanotubes; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermogravimetry; Titanium | 2017 |
Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach.
Topics: Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Biphenyl Compounds; Crystallization; Drug Combinations; Female; Hydrochlorothiazide; Irbesartan; Rats; Rats, Wistar; Solubility; Telmisartan; Tetrazoles | 2017 |
Hansen solubility parameters for assay method optimization of simvastatin, ramipril, atenolol, hydrochlorothiazide and aspirin in human plasma using liquid chromatography with tandem mass spectrometry.
Topics: Aspirin; Atenolol; Chromatography, Liquid; Humans; Hydrochlorothiazide; Ramipril; Reproducibility of Results; Simvastatin; Solubility; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2017 |
Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: Enhanced physical stability, dissolution and pharmacokinetic profile.
Topics: Animals; Antihypertensive Agents; Atenolol; Biological Availability; Drug Combinations; Drug Compounding; Drug Interactions; Drug Liberation; Drug Stability; Hydrochlorothiazide; Male; Rats, Sprague-Dawley | 2017 |
Cytotoxic and genotoxic effects of antihypertensives distributed in Brazil by social programs: Are they safe?
Topics: Antihypertensive Agents; Atenolol; Brazil; Captopril; Cell Survival; Cells, Cultured; DNA Damage; Dose-Response Relationship, Drug; Enalapril; Government Programs; Humans; Hydrochlorothiazide; Hypertension; Losartan; Lymphocytes; Macrophages; Male; Mutagenicity Tests; Program Evaluation; Propranolol | 2018 |
Molecular conformation, vibrational spectroscopic and NBO analysis of atenolol and atenolol-hydrochlorothiazide cocrystals.
Topics: Adrenergic beta-1 Receptor Antagonists; Antihypertensive Agents; Atenolol; Crystallization; Crystallography, X-Ray; Density Functional Theory; Hydrochlorothiazide; Models, Molecular; Molecular Conformation; Static Electricity | 2019 |
Analysis of quinary therapy targeting multiple cardiovascular diseases using UV spectrophotometry and chemometric tools.
Topics: Algorithms; Aspirin; Atenolol; Capsules; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Humans; Hydrochlorothiazide; Least-Squares Analysis; Ramipril; Simvastatin; Spectrophotometry, Ultraviolet | 2020 |
High-Silica Zeolites as Sorbent Media for Adsorption and Pre-Concentration of Pharmaceuticals in Aqueous Solutions.
Topics: Adsorption; Atenolol; Hydrochlorothiazide; Ketoprofen; Porosity; Silicon Dioxide; Solid Phase Extraction; Solvents; Surface Properties; Water; Water Pollutants, Chemical; Zeolites | 2020 |
Application of Quality Risk Assessment and DoE-Based Enhanced Analytical Quality by Design Approach to Development of Chromatography Method for Estimation of Combined Pharmaceutical Dosage Form of Five Drugs.
Topics: Atenolol; Chromatography, High Pressure Liquid; Hydrochlorothiazide; Pharmaceutical Preparations; Risk Assessment | 2021 |
Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Coronary Artery Disease; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Proportional Hazards Models; Randomized Controlled Trials as Topic; Sex Factors; Verapamil | 2021 |
Development of a multivariate model with desirability-based optimization for determination of atenolol and hydrochlorothiazide by eco-friendly HPLC method with fluorescence detection.
Topics: Antihypertensive Agents; Atenolol; Chromatography, High Pressure Liquid; Hydrochlorothiazide | 2022 |